Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Immunosuppressive humanized antibodies designed by LG Chemical

July 11, 2000

Genetic cause of lymphedema discovered by U. of Pittsburgh researchers

July 11, 2000

Positive results reported by Biovector from second phase I trial of nasal flu vaccine

July 10, 2000

Amarillo Biosciences and Hayashibara to develop inhalable interferon gamma

July 10, 2000

R-848 potently modulates IgE synthesis in PBMCs from normal and allergic donors

July 7, 2000

InterMune acquires additional rights to Actimmune

July 7, 2000

Kosan receives NIH grant to develop novel immunosuppressants

July 6, 2000

Innogenetics patents immunotoxins for use in immune disorders and certain malignancies

July 5, 2000

CPMP adopts positive opinion for new pediatric vaccines from SB

July 5, 2000

Peptides useful in toxic shock syndrome discovered by Rockefeller U. researchers

July 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.